On September 30, 2021, the European Medicines Agency (EMA) released a report entitled “Tailored Scientific Advice for Biosimilar Development,” describing results from its pilot program in which biosimilar applicants were...more
12/6/2021
/ Biologics ,
Biosimilars ,
EU ,
European Economic Area (EEA) ,
European Medicines Agency (EMA) ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Information Reports ,
Pharmaceutical Industry ,
Pilot Programs ,
Prescription Drugs